On the other hand, schizophrenia patients without AVHs showed ALFF changes predominantly linked to the dopaminergic, serotonergic, (GABAa)ergic and cholinergic neurotransmitter systems, mainly involving the vesicular acetylcholine transporter. Here, SLC18A3 is linked to schizophrenia.